Form 8.3 - ARK THERAPEUTICS
April 22 2010 - 5:33AM
UK Regulatory
TIDMAKT
RNS Number : 6240K
Standard Life Investments
22 April 2010
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
+--------------------+--------------+
| (a) | STANDARD |
| Identity | LIFE |
| of the | INVESTMENTS |
| person | |
| whose | |
| positions/dealings | |
| are being | |
| disclosed: | |
+--------------------+--------------+
| (b) | N/A |
| Owner | |
| or | |
| controller | |
| of | |
| interests | |
| and short | |
| positions | |
| disclosed, | |
| if | |
| different | |
| from 1(a): | |
| The | |
| naming of | |
| nominee or | |
| vehicle | |
| companies | |
| is | |
| insufficient | |
+--------------------+--------------+
| (c) | ARK |
| Name | THERAPEUTICS |
| of | |
| offeror/offeree | |
| in relation to | |
| whose relevant | |
| securities this | |
| form relates: | |
| Use a | |
| separate form | |
| for each | |
| offeror/offeree | |
+--------------------+--------------+
| (d) If | N/A |
| an | |
| exempt | |
| fund | |
| manager | |
| connected | |
| with an | |
| offeror/offeree, | |
| state this and | |
| specify identity | |
| of | |
| offeror/offeree: | |
+--------------------+--------------+
| (e) | 21/04/10 |
| Date | |
| position | |
| held/dealing | |
| undertaken: | |
+--------------------+--------------+
| (f) | NO |
| Has | |
| the | |
| discloser | |
| previously | |
| disclosed, | |
| or are | |
| they today | |
| disclosing, | |
| under the | |
| Code in | |
| respect of | |
| any other | |
| party to | |
| this offer? | |
+--------------------+--------------+
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
(a) Interests and short positions in the relevant securities of the
offeror or offeree to which the disclosure relates following the dealing (if
any)
+----------------+--------------+--------+--------+--------+
| Class | ORD GBP 0.01 |
| of | |
| relevant | |
| security: | |
| | |
+----------------+-----------------------------------------+
| | Interests |Short positions |
| | | |
+ +-----------------------+-----------------+
| | Number | % |Number | % |
+----------------+--------------+--------+--------+--------+
| (1) |6,938,370.00 | 3.32 | | |
| Relevant | | | | |
| securities | | | | |
| owned | | | | |
| and/or | | | | |
| controlled: | | | | |
+----------------+--------------+--------+--------+--------+
| (2) | | | | |
| Derivatives | | | | |
| (other than | | | | |
| options): | | | | |
+----------------+--------------+--------+--------+--------+
| (3) | | | | |
| Options | | | | |
| and | | | | |
| agreements | | | | |
| to | | | | |
| purchase/sell: | | | | |
+----------------+--------------+--------+--------+--------+
| |6,938,370.00 | 3.32 | | |
| | | | | |
| TOTAL: | | | | |
+----------------+--------------+--------+--------+--------+
All interests and all short positions should be disclosed.
Details of any open derivative or option positions, or agreements to purchase or
sell relevant securities, should be given on a Supplemental Form 8 (Open
Positions).
(b) Rights to subscribe for new securities (including directors' and
other executive options)
+--------------+--------+
| Class | |
| of | |
| relevant | |
| security | |
| in | |
| relation | |
| to which | |
| subscription | |
| right | |
| exists: | |
+--------------+--------+
| Details, | |
| including | |
| nature of | |
| the | |
| rights | |
| concerned | |
| and | |
| relevant | |
| percentages: | |
+--------------+--------+
If there are positions or rights to subscribe to disclose in more than one class
of relevant securities of the offeror or offeree named in 1(c), copy table 2(a)
or (b) (as appropriate) for each additional class of relevant security.
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
(a) Purchases and sales
+----------+---------------+------------+--------+
| Class |Purchase/sale | Number | Price |
| of | | of | per |
|relevant | |securities | unit |
|security | | | |
+----------+---------------+------------+--------+
| ORD | SALE | 500,000 | GBP |
| GBP | | | 0.1 |
| 0.01 | | | |
+----------+---------------+------------+--------+
(b) Derivatives transactions (other than options)
+----------+-------------+---------------------+------------+--------+
| Class | Product | Nature | Number | Price |
| of |description | of | of | per |
|relevant | e.g. CFD | dealing | reference | unit |
|security | | e.g. |securities | |
| | | opening/closing | | |
| | | a long/short | | |
| | | position, | | |
| | |increasing/reducing | | |
| | | a long/short | | |
| | | position | | |
+----------+-------------+---------------------+------------+--------+
| | | | | |
| | | | | |
+----------+-------------+---------------------+------------+--------+
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
+----------+-------------+-------------+------------+----------+-----------+--------+----------+
| Class | Product | Writing, | Number |Exercise | Type |Expiry | Option |
| of |description |purchasing, | of | price | e.g. | date | money |
|relevant | e.g. call | selling, |securities |per unit |American, | | paid/ |
|security | option | varying | to which | | European | |received |
| | | etc. | option | | etc. | |per unit |
| | | | relates | | | | |
+----------+-------------+-------------+------------+----------+-----------+--------+----------+
| | | | | | | | |
+----------+-------------+-------------+------------+----------+-----------+--------+----------+
(ii) Exercising
+----------+-------------+------------+----------+
| Class | Product | Number |Exercise |
| of |description | of | price |
|relevant | e.g. call |securities |per unit |
|security | option | | |
Premier Veterinary (LSE:PVG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Premier Veterinary (LSE:PVG)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Premier Veterinary Group Plc (London Stock Exchange): 0 recent articles
More Ark Therapeutics News Articles